Moreover, studies on adult female mice bearing ErbB2-driven breast tumors have shown that inhibition of cyclin D-CDK kinase activity can trigger tumor cell senescence and prevent the progression of breast cancer (Choi et al., 2012). The gene discussed is ERBB2; the disease is breast cancer.